Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
9.15
-0.30 (-3.17%)
Jun 13, 2025, 2:45 PM CST

SHA:603229 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
1,1051,0961,124608.85564.55739.11
Upgrade
Trading Asset Securities
4.942.24-4.02110-
Upgrade
Cash & Short-Term Investments
1,1101,0991,124612.87674.55739.11
Upgrade
Cash Growth
-1.29%-2.29%83.44%-9.14%-8.73%116.06%
Upgrade
Accounts Receivable
331.1196.58132.75134.8166.2445.56
Upgrade
Other Receivables
2.571.632.828.491.490.84
Upgrade
Receivables
333.67198.21135.57143.367.7346.4
Upgrade
Inventory
384.36400.95365.18320.57243.44190.17
Upgrade
Other Current Assets
8.6311.4849.7559.9734.864.25
Upgrade
Total Current Assets
1,8361,7091,6751,1371,021979.93
Upgrade
Property, Plant & Equipment
1,0531,0411,046950.94601.46299.92
Upgrade
Long-Term Investments
72.5672.5667.3750.1432.6413.08
Upgrade
Other Intangible Assets
154.48155.39150.37161.98164.277.3
Upgrade
Long-Term Deferred Tax Assets
-0.46-6.874.474.72
Upgrade
Other Long-Term Assets
4.543.9912.718.6916.16.74
Upgrade
Total Assets
3,1212,9822,9522,3151,8391,382
Upgrade
Accounts Payable
370.78351.64410.85519.32402.25171.26
Upgrade
Accrued Expenses
40.3946.8740.1142.9131.6322.35
Upgrade
Short-Term Debt
290.09270.31300.26160.1265.0741.04
Upgrade
Current Portion of Long-Term Debt
---9.16--
Upgrade
Current Portion of Leases
-1.040.87---
Upgrade
Current Income Taxes Payable
-2.5310.21-5.811.74
Upgrade
Current Unearned Revenue
10.120.917.0612.6323.232.53
Upgrade
Other Current Liabilities
3.051.231.611.282.334.95
Upgrade
Total Current Liabilities
714.43674.53770.97745.42530.32243.87
Upgrade
Long-Term Debt
---72.7444.86-
Upgrade
Long-Term Leases
1.021.082.04---
Upgrade
Long-Term Unearned Revenue
33.2534.8934.9123.519.4610.94
Upgrade
Long-Term Deferred Tax Liabilities
0.08-2.0712.51--
Upgrade
Total Liabilities
748.79710.5809.99854.19584.64254.81
Upgrade
Common Stock
830.3830.3593.07401.87287.05239.21
Upgrade
Additional Paid-In Capital
440.23440.23677.45394.72509.54557.38
Upgrade
Retained Earnings
1,1041,002871.92665.46459.36331.37
Upgrade
Comprehensive Income & Other
-0.16-0.83-0.86-0.91-1.14-1.08
Upgrade
Shareholders' Equity
2,3722,2722,1421,4611,2551,127
Upgrade
Total Liabilities & Equity
3,1212,9822,9522,3151,8391,382
Upgrade
Total Debt
291.11272.43303.17242.02109.9341.04
Upgrade
Net Cash (Debt)
818.63826.1821.06370.85564.62698.06
Upgrade
Net Cash Growth
-0.29%0.61%121.40%-34.32%-19.12%134.94%
Upgrade
Net Cash Per Share
0.981.001.000.460.710.94
Upgrade
Filing Date Shares Outstanding
851.42828.3830.3787.66787.66787.66
Upgrade
Total Common Shares Outstanding
851.42830.3830.3787.66787.66787.66
Upgrade
Working Capital
1,1221,035903.76391.28490.26736.06
Upgrade
Book Value Per Share
2.792.742.581.861.591.43
Upgrade
Tangible Book Value
2,2172,1161,9911,2991,0911,050
Upgrade
Tangible Book Value Per Share
2.602.552.401.651.381.33
Upgrade
Buildings
-261.11224.84168.11150.71135.9
Upgrade
Machinery
-559.12510.1278.07223.16211.87
Upgrade
Construction In Progress
-495.66526.23685.01379.2477.04
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.